Buy N-Acetyl Semax Amidate 20 mg

€32.39

N-Acetyl Semax Amidate, 20 mg, is a terminally modified seven-residue peptide for analytical and in vitro laboratory research. Pharma Research .eu provides documented European supply subject to lot-specific purity, identity and net-content verification.

Category:
Description

Buy N-Acetyl Semax Amidate, 20 mg, for Advanced Laboratory Research in Europe

N-Acetyl Semax Amidate is a chemically defined, terminally modified seven-residue Semax analogue used as a laboratory reagent in peptide analytics, structure–stability studies and controlled in vitro research. The verified structure is Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NHβ‚‚, with formula C₃₉Hβ‚…β‚„N₁₀O₁₀S, CAS Registry Number 2920938-90-3 and average molecular mass approximately 854.97 Da. Pharma Research .eu presents this 20 mg format for qualified European laboratory teams requiring documented peptide materials.pubchem.ncbi.nlm.nih+2

Uncompromising Purity and Analytical Characterisation

N-Acetyl Semax Amidate should be specified as:

Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NHβ‚‚

The N-terminal acetyl group and C-terminal amide are essential structural features. This compound should not be confused with free Semax, N-acetyl Semax without C-terminal amidation or other analogues. These related materials have different formulae, molecular masses and analytical behaviours.artemispeptides

For laboratory procurement, the suitable target is β‰₯99.0% purity by RP-HPLC or LC-MS, subject to confirmation by the actual batch-specific certificate of analysis. Independent lot reports have shown high purity and measured content above the nominal 20 mg label, but such results apply only to the tested lots and should not be generalised to every supplier.peptigrity+1

A complete CoA should include:

  • RP-HPLC purity percentage, method and chromatogram.

  • LC-MS, ESI-MS or high-resolution MS identity confirmation.

  • Full sequence with acetylation and amidation explicitly stated.

  • Molecular formula and molecular-mass assignment.

  • Free-peptide, acetate or other salt-form information.

  • Net peptide content, separately reported from vial overfill.

  • Visual appearance of the lyophilised material.

  • Residual-solvent results from synthesis and purification.

  • Water or residual-moisture content, where measured.

  • Heavy-metal or elemental-impurity results where included in the quality programme.

  • Lot number, manufacture date, retest date and storage requirements.

The commonly reported formula is C₃₉Hβ‚…β‚„N₁₀O₁₀S, with molecular mass approximately 854.97–855.0 g/mol and exact mass approximately 854.3745 Da. PubChem CID 172638603 and CAS 2920938-90-3 are associated with this defined structure.pubchem.ncbi.nlm.nih+3

The product is generally supplied as a white to off-white lyophilised powder. Visual inspection can identify gross discolouration, vial damage or visible contamination, but cannot establish identity or purity. Analytical release should combine appearance assessment with RP-HPLC and mass-spectral confirmation.

High purity is important because methionine may undergo oxidation, while incomplete acetylation, incomplete amidation, deletion sequences and residual synthesis reagents may create closely related impurities. These species can alter retention time, ionisation, solubility, proteolytic stability and assay response. A nominal 20 mg quantity should also be distinguished from measured net content, since some commercial CoAs report overfill.peptigrity+1

Principal Laboratory Applications and Research Methodologies

N-Acetyl Semax Amidate is suitable for controlled laboratory research involving modified-peptide chemistry, analytical characterisation and in vitro neurobiological model development. All applications should be conducted by qualified personnel within an appropriately governed university, CRO, pharmaceutical R&D or analytical laboratory.

RP-HPLC and LC-MS method development. The peptide can serve as a defined modified-sequence analyte for retention-time assignment, intact-mass confirmation and impurity profiling. Methods should distinguish the principal compound from free Semax, singly modified forms, incomplete capping and methionine-oxidised species.

Comparative structure–stability studies. Laboratories may compare N-Acetyl Semax Amidate with Semax and other terminally modified analogues to investigate effects on chromatographic retention, molecular-ion response, aqueous stability and degradation. Comparisons should use matched purity, concentration and solvent conditions.

Oxidation and degradation research. The methionine residue permits controlled monitoring of oxidation-related changes. Researchers may examine temperature, light, pH and oxidative-stress conditions using HPLC and mass spectrometry. Apparent loss should be distinguished from adsorption, precipitation or incomplete dissolution.

In vitro biochemical and cellular models. A verified lot may be incorporated into controlled cell-free or cellular systems examining peptide-associated signalling or neurotrophic read-outs. Experimental plans should include vehicle controls, matrix blanks, concentration confirmation and independent verification of peptide integrity during incubation.

The 20 mg nominal quantity corresponds to approximately 23.4 Β΅mol using the reported molecular mass of 854.97 g/mol. If a CoA reports a different net content, the molar quantity should be recalculated using the measured amount and correct salt form. No working concentration should be stated without a defined final volume and validated preparation method.

If bacteriostatic water is supplied separately, its preservative composition should be evaluated for compatibility with LC-MS and in vitro workflows. Solvent blanks, matrix-effect testing and cell-compatibility controls may be required.

Compound Stability, Optimal Storage, and Safe Handling Protocols

The lyophilised peptide should remain sealed, dry and protected from light until required for a validated procedure. Research references commonly recommend low-temperature storage, often at approximately βˆ’20Β°C. Prepared solutions are generally less stable than the dry material and require compound- and formulation-specific validation.peptidelibrary+1

Recommended controls include:

  • Store unopened lyophilised material at βˆ’20Β°C unless the CoA specifies otherwise.

  • Consider βˆ’80Β°C for extended archival storage where supported by the stability programme.

  • Keep the container tightly closed, dry and protected from direct light.

  • Allow a sealed vial to reach room temperature before opening to minimise condensation.

  • Use low-binding tubes where adsorption could affect recovery.

  • Prepare aliquots if repeated access is expected.

  • Store short-term aqueous solutions at 2–8Β°C only where validated.

  • Use frozen aliquots for longer-term solution storage when supported by stability data.

  • Avoid repeated freeze–thaw cycles.

  • Monitor methionine oxidation during extended storage or stress studies.

  • Record solvent, concentration, preparation date, operator and storage history.

The acetyl and amide modifications may alter stability relative to free Semax, but they do not eliminate oxidation, adsorption or concentration-loss risks. A clear solution should not be assumed to retain full chemical integrity without chromatographic or mass-spectral confirmation.

Reconstitution should be carried out using a validated laboratory procedure. Add the selected solvent gradually, allow the powder to hydrate and mix gently. Avoid vigorous agitation unless its compatibility has been demonstrated. If the prepared solution becomes cloudy or develops particulates, it should be investigated analytically before use.

Handling should follow the current SDS and institutional chemical-risk assessment. Appropriate precautions generally include a certified fume hood or suitable local containment, nitrile gloves, safety goggles and a laboratory coat. Avoid aerosol generation and direct contact with the powder or solution. Dispose of contaminated materials through approved institutional chemical and laboratory-waste procedures.

Technical Specifications and Molecular Attributes

Attribute Specification
Product N-Acetyl Semax Amidate, 20 mg
Common designation Acetylated and amidated Semax analogue
Sequence Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NHβ‚‚
Residue count 7 amino acids
IUPAC name N-acetyl-L-methionyl-L-glutamyl-L-histidyl-L-phenylalanyl-L-prolyl-glycyl-L-prolinamide; confirm stereochemistry on the CoA
CAS Registry Number 2920938-90-3
Molecular formula C₃₉Hβ‚…β‚„N₁₀O₁₀S
Average molecular mass Approximately 854.97–855.0 g/mol
Exact mass Approximately 854.3745 Da
Physical state and colour Lyophilised white to off-white powder
Solubility profile Aqueous reconstitution may be feasible; solvent and buffer compatibility require assay-specific validation
Typical purity Proposed target β‰₯99.0% by RP-HPLC or LC-MS; verify the lot-specific result
Identity testing LC-MS, ESI-MS or high-resolution MS
Long-term storage Typically βˆ’20Β°C, sealed and protected from light and moisture

The formula, sequence, CAS number and molecular mass correspond to the defined N-acetylated, C-amidated structure. Listings that show the free Semax formula C₃₇H₅₁N₉O₁₀S under this product name should be treated as identity errors until corrected.pubchem.ncbi.nlm.nih+3

Pharma Research .eu: Your Premier EU Vendor for High-Purity Reagents

Pharma Research .eu can position N-Acetyl Semax Amidate as a documented European laboratory reagent for analytical chemists, biochemists and pharmacology research teams requiring a defined modified peptide. The product file should include a batch-specific CoA, SDS, sequence designation, terminal-group confirmation, purity result, identity data, net content, salt-form information and storage instructions.

Any claim that Pharma Research .eu operates an ISO 9001-certified quality-management system should be supported by a current certificate identifying the issuing body, scope and validity. Claims concerning discreet or temperature-controlled logistics across EU member states should likewise be verified for the destination, carrier route, packaging and applicable transport requirements.

A quality-focused supplier should be able to discuss:

  • The distinction between free Semax and N-Acetyl Semax Amidate.

  • N-terminal acetylation and C-terminal amidation.

  • Methionine-oxidation monitoring.

  • RP-HPLC purity and LC-MS identity testing.

  • Measured net content versus nominal 20 mg fill.

  • Residual solvents, moisture and elemental-impurity reporting.

  • Packaging configuration and container-closure integrity.

  • Storage, transport and documentation requirements.

Pharma Research .eu should therefore be described as a potential European source for research-grade N-Acetyl Semax Amidate, with vendor-specific certification and logistics claims verified through current records. The material is intended strictly for controlled laboratory research and analytical use by qualified personnel under applicable institutional procedures.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy N-Acetyl Semax Amidate 20 mg”

Your email address will not be published. Required fields are marked *

Shipping & Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisqueΒ vestibulum amet elit ut volutpat.